✦ LIBER ✦

Paroxetine controlled release is effective in treating premenstrual dysphoric disorder

✍ Scribed by Lee S. Cohen; Claudio N. Soares; Kimberly A. Yonkers; Kevin M. Bellew; Ian M. Bridges; Vicki L. Heller

Book ID: 117191589
Publisher: Lippincott Williams and Wilkins
Year: 2003
Tongue: English
Weight: 53 KB
Volume: 101
Category: Article
ISSN: 0029-7844
DOI: 10.1016/s0029-7844(02)03026-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Paroxetine controlled release is effecti

Paroxetine controlled release is effective in treating premenstrual dysphoric disorder: a pooled analysis of three trials

✍ Kimberly A. Yonkers; Brian N. Hunter; Kevin M. Bellew; Timothy E. Rolfe; Meir St 📂 Article 📅 2003 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 60 KB

Luteal phase dosing with paroxetine cont

Luteal phase dosing with paroxetine controlled release (CR) in the treatment of premenstrual dysphoric disorder

✍ Meir Steiner; Angelica Lindén Hirschberg; Richard Bergeron; Fiona Holland; Miche 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 254 KB

A new low-dose, drospirenone-containing

A new low-dose, drospirenone-containing oral contraceptive (OC) with a new dosing regimen is effective in reducing premenstrual dysphoric disorder (PMDD)

✍ K.A. Yonkers; M.L. Foegh 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 30 KB

Paroxetine is effective in the treatment

Paroxetine is effective in the treatment of generalized anxiety disorder: results from a randomized placebo-controlled flexible dose study

✍ J.P. McCafferty; K. Bellew; R. Zanelli; M. Iyengar; K. Hewett 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 285 KB

Allopregnanolone has no effect on startl

Allopregnanolone has no effect on startle response and prepulse inhibition of startle response in patients with premenstrual dysphoric disorder or healthy controls

✍ Kristiina Kask; Torbjörn Bäckström; Per Lundgren; Inger Sundström Poromaa 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 335 KB

Binding of [3H]paroxetine to serotonin u

Binding of [3H]paroxetine to serotonin uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment

✍ M. Bixo; P. Allard; T. Bäckström; T. Mjörndal; S. Nyberg; O. Spigset; I. Sundstr 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 124 KB